
Genetic Technologies (GENE) P/E Ratio
P/E Ratio as of Nov 6, 2025: -0.55
Average-0.5500
Median-0.5500
Minimum-0.5500
Maximum-0.5500
-0.55
Past Month0.00 (0.00%)
The P/E ratio for Genetic Technologies (GENE) is -0.55 as of Nov 6, 2025. This represents a increase of 25.00% compared to its 12-month average P/E ratio of -0.44. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Genetic Technologies P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Genetic Technologies’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Genetic Technologies to industry peers.
Genetic Technologies P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Genetic Technologies’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Genetic Technologies to industry peers.
Genetic Technologies (GENE) P/E Ratio Insights
See Genetic Technologies’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Genetic Technologies (GENE)
Order type
Buy in
Order amount
Est. shares
0 shares
Genetic Technologies (GENE) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Nov 3, 2025 | — | -0.55 |
| Oct 1, 2025 | — | -0.55 |
| Sep 2, 2025 | — | -0.55 |
| Aug 1, 2025 | — | -0.40 |
| Jul 1, 2025 | — | -0.40 |
| Jun 2, 2025 | — | -0.40 |
| May 1, 2025 | — | -0.40 |
| Apr 1, 2025 | — | -0.40 |
| Mar 3, 2025 | — | -0.40 |
| Feb 3, 2025 | — | -0.40 |
| Jan 2, 2025 | — | -0.40 |
Genetic Technologies (GENE) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.55 | +37.50% |
| 2024 | -0.40 | -59.60% |
| 2023 | -0.99 | -66.21% |
| 2022 | -2.93 | -45.44% |
| 2021 | -5.37 | -36.90% |
| 2020 | -8.51 | — |
FAQs About Genetic Technologies (GENE) P/E ratio
The latest P/E ratio of Genetic Technologies (GENE) is -0.55, as of Nov 6, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Genetic Technologies’s last 12-month average P/E ratio is -0.44, compared to its current P/E ratio of -0.55. This reflects a increase of 25.00%.
Genetic Technologies’s current P/E ratio of -0.55 is higher than its last 12-month average P/E of -0.44. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Genetic Technologies’s average P/E ratio over the last 3 years is -1.23. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Genetic Technologies’s average P/E ratio over the last 5 years is -3.64. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.